Quick Answer
Mosaic ImmunoEngineering Inc. reported Common Stock Shares Outstanding of 7.24 million shares for the year ending 2024.
- Mosaic ImmunoEngineering Inc. showed an increase of +0.0% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Mosaic ImmunoEngineering Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2011 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2024), Mosaic ImmunoEngineering Inc.'s Common Stock Shares Outstanding has declined by 98.2%.
- Historical annual values: Fiscal year 2024: 7.24 million shares | Fiscal year 2023: 7.24 million shares | Fiscal year 2022: 7.24 million shares | Fiscal year 2021: 7.24 million shares | Fiscal year 2020: 805,803 shares | Fiscal year 2020: 401.39 million shares | Fiscal year 2019: 401.39 million shares | Fiscal year 2018: 401.39 million shares | Fiscal year 2017: 401.39 million shares | Fiscal year 2016: 401.39 million shares | Fiscal year 2015: 401.39 million shares | Fiscal year 2014: 401.39 million shares | Fiscal year 2013: 405.25 million shares | Fiscal year 2012: 405.74 million shares | Fiscal year 2011: 407.53 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: